Wedge Capital Management L L P Meridian Bioscience Inc Transaction History

Wedge Capital Management L L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$13.54 - $26.41 $1.37 Million - $2.68 Million	-101,537 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$7.84 - $23.29 $553,378 - $1.64 Million	70,584 Added 228.04%	101,537 $2.37 Million
Q1 2020 Apr 13, 2020	BUY	$5.57 - $11.5 $24,691 - $50,979	4,433 Added 16.72%	30,953 $260,000
Q4 2019 Jan 15, 2020	BUY	$7.9 - $10.14 $11,826 - $15,179	1,497 Added 5.98%	26,520 $259,000
Q3 2019 Nov 01, 2019	SELL	$9.17 - $12.01 $150,910 - $197,648	-16,457 Reduced 39.67%	25,023 $237,000
Q2 2019 Aug 01, 2019	BUY	$10.88 - $17.6 $451,302 - $730,048	41,480 New	41,480 $493,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.